Happy holidays!

With today's issue, we're concluding another year's coverage of the pharma industry. FiercePharma and its sister publications will be taking a publishing holiday until January 5th, when we'll be back with our annual forecast for the industry, including a look at FiercePharma's most popular stories of 2008. Enjoy the holidays and look for us in the New Year! - Maureen

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.